Biocompatible Fe3O4 increases the efficacy of amoxicillin delivery against gram-positive and gram-negative bacteria

Molecules

Volumn 19, Issue 4, 2014, Pages 5013-5027

  Grumezescu, Alexandru Mihai ^a   Gesta, Monica Cartelle ^a,b   Holban, Alina Maria ^c   Grumezescu, Valentina ^a   Vasile, Bogdan Stefan ^a   Mogoanta, Laurentiu ^d   Iordache, Florin ^e   Bleotu, Coralia ^f   Dan Mogosanu, George ^d  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^b Ministry of Public Health   (Ecuador)

^c UNIVERSITY OF BUCHAREST   (Romania)

^d UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^e INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^f STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

Amoxicillin; E. coli; Magnetite bio active nanostructure; MIC; S. aureus

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; DRUG CARRIER; MAGNETITE; MAGNETITE NANOPARTICLE;

ANIMAL; CELL CYCLE; CELL LINE; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY; LUNG; METABOLISM; MOUSE; PARTICLE SIZE; SPLEEN; STAPHYLOCOCCUS AUREUS;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CELL CYCLE; CELL LINE; DRUG CARRIERS; DRUG SYNERGISM; ESCHERICHIA COLI; FERROSOFERRIC OXIDE; HUMANS; KIDNEY; LUNG; MAGNETITE NANOPARTICLES; MICE; PARTICLE SIZE; SPLEEN; STAPHYLOCOCCUS AUREUS;

EID: 84899574770     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19045013     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. Antibiotic Resistance Questions & Answers. In Get Smart: Know When Antibiotics Work Homepage. Available online: http://www.cdc.gov/getsmart/ antibiotic-use/antibiotic- resistance-faqs.html (accessed on 6 June 2009. Retrieved December 2013).
2. Cartelle, M.; Canle, D.; Llarena, F.J.; Molina, F.; Villanueva, R.; Bou, G. Characterisation of the first CTX-M-10-producing isolate of Salmonella enterica serotype Virchow. Clin. Microbiol. Infect. 2006, 12, 285-287.
3. Cartelle, M.; del Mar Tomas, M.; Molina, F.; Moure, R.; Villanueva, R.; Bou, G. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob. Agents Chemother. 2004, 48, 2308-2313.
4. Xie, J.; Pierce, J.G.; James, R.C.; Okano, A.; Boger, D.L. A redesigned vancomycin engineered for dual D-Ala-D-Ala and D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria. J. Am. Chem. Soc. 2011, 133, 13946-13949.
5. Boyle-Vavra, S.; Daum, R.S. Community-acquired methicillin-resistant Staphylococcus aureus: The role of Panton-Valentine leukocidin. Lab. Investig. 2007, 87, 3-9.
6. Sodha, S.V.; Lynch, M.; Wannemuehler, K.; Leeper, M.; Malavet, M.; Schaffzin, J. Multistate outbreak of Escherichia coli O157:H7 infections associated with a national fast-food chain, 2006: A study incorporating epidemiological and food source traceback results. Epidemiol. Infect. 2011, 139, 309-316.
7. Bou, G.; Cartelle, M.; Tomas, M.; Canle, D.; Molina, F.; Moure, R.; Eiros, J.M.; Guerrero, A. Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain. J. Clin. Microbiol. 2002, 40, 4030-4036.
8. Tadesse, D.A.; Zhao, S.; Tong, E.; Ayers, S.; Singh, A.; Bartholomew, M.J.; McDermott, P.F. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States. Emerg. Infect. Dis. 2012, 18, 741-749.
9. Poole, K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 2004, 10, 12-26.
10. Louw, G.E.; Warren, R.M.; Gey van Pittius, N.C.; McEvoy, C.R.E.; van Helden, P.D.; Victor, T.C. A balancing act: Efflux/influx in mycobacterial drug resistance. Antimicrob. Agents Chemother. 2009, 53, 3181-3189.
11. Grumezescu, A.M.; Vasile, B.S.; Holban, A.M. Eugenol functionalized magnetite nanostructures used in anti-infectious therapy. Lett. Appl. NanoBioSci. 2013, 2, 120-123.
12. Holban, A.M.; Grumezescu, A.M.; Andronescu, E.; Grumezescu, V.; Chifiriuc, C.M.; Radulescu, R. Magnetite-usnic acid nanostructured bioactive material with antimicrobial activity. Rom. J. Mater. 2013, 43, 402-407.
13. Holban, A.M.; Grumezescu, A.M.; Ficai, A.; Chifiriuc, C.M.; Lazar, V.; Radulescu, R. Fe3O4@C18-carvone to prevent Candida tropicalis biofilm development. Rom. J. Mater. 2013, 43, 300-350.
14. Chifiriuc, M.C.; Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Cotar, A.I.; Grumezescu, V.; Bezirtzoglou, E.; Lazar, V.; Radulescu, R. Water dispersible magnetite nanoparticles influence the efficacy of antibiotics agains planktonic and biofilm embedded Enterococcus faecalis cells. Anaerobe 2013, 22, 14-19.
15. Grumezescu, A.M.; Cotar, A.I.; Andronescu, E.; Ficai, A.; Ghitulica, C.D.; Grumezescu, V.; Vasile, B.S.; Chifiriuc, M.C. In vitro activity of the new water dispersible Fe3O4@usnic acid nanostructure against planktonic and sessile bacterial cells. J. Nanopart. Res. 2013, 15, 1766.
16. Cotar, A.I.; Grumezescu, A.M.; Huang, K.-S.; Chifiriuc, C.M.; Radulescu, R. Magnetite nanoparticles influence the efficacy of antibiotics against biofilm embedded Staphylococcus aureus cells. Biointerface Res. Appl. Chem. 2013, 3, 559-565.
17. Cotar, A.I.; Grumezescu, A.M.; Andronescu, E.; Voicu, G.; Ficai, A.; Ou, K.-L.; Huang, K.-S.; Chifiriuc, M.C. Nanotechnological solution for improving the antibiotic efficiency against biofilms developed by gram-negative bacterial strains. Lett. Appl. NanoBioSci. 2013, 2, 97-104.
18. Grumezescu, A.M.; Andronescu, E.; Grumezescu, V.; Bleotu, C.; Saviuc, C.; Mihaiescu, D.E.; Chifiriuc, C.M. Biocompatible magnetic hollow silica microspheres for drug delivery. Curr. Org. Chem. 2013, 17, 1029-1033.
19. Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Ficai, D.; Huang K.S.; Gheorghe, I.; Chifiriuc, M.C. Water soluble magnetic biocomposite with potential applications for the antimicrobial therapy. Biointerface Res. Appl. Chem. 2012, 2, 469-475.
20. Grumezescu, A.M.; Holban, A.M.; Andronescu, E.; Ficai, A.; Bleotu, C.; Chifiriuc, M.C. Water dispersible metal oxide nanobiocomposite as a potentiator of the antimicrobial activity of kanamycin. Lett. Appl. NanoBioSci. 2012, 1, 77-82.
21. Grumezescu, A.M.; Andronescu, E.; Holban, A.M.; Ficai, A.; Ficai, D.; Voicu, G.; Grumezescu, V.; Balaure, P.C.; Chifiriuc, C.M. Water dispersible cross-linked magnetic chitosan beads for increasing the antimicrobial efficiency of aminoglycoside antibiotics. Int. J. Pharm. 2013, 454, 233-240.
22. Philosof-Mazor, L.; Dakwar, G.R.; Popov, M.; Kolusheva, S.; Shames, A.; Linder, C.; Greenberg, S.; Heldman, E.; Stepensky, D.; Jelinek, R. Bolaamphiphilic vesicles encapsulating iron oxide nanoparticles: New vehicles for magnetically targeted drug delivery. Int. J. Pharm. 2013, 450, 241-249.
23. Ladj, R.; Bitar, A.; Eissa, M.M.; Fessi, H.; Mugnier, Y.; le Dantec, R.; Elaissari, A. Polymer encapsulation of inorganic nanoparticles for biomedical applications. Int. J. Pharm. 2013, 458, 230-241.
24. Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Bleotu, C.; Mihaiescu, D.E.; Chifiriuc, M.C. Synthesis, characterization and in vitro assessment of the magnetic chitosan-carboxymethylcellulose biocomposite interactions with the prokaryotic and eukaryotic cells. Int. J. Pharm. 2012, 436, 771-777.
25. Chifiriuc, M.C.; Grumezescu, A.M.; Saviuc, C.; Croitoru, C.; Mihaiescu, D.E.; Lazar, V. Improved antibacterial activity of cephalosporins loaded in magnetic chitosan microspheres. Int. J. Pharm. 2012, 436, 201-205.
26. Li, Y.; Jiangn, R.; Liu, T.; Lv, H.; Zhang, X. Single-microemulsion-based solvothermal synthesis of magnetite microflowers. Ceram. Int. 2014, 40, 4791-4795.
27. Jiang, W.; Wu, Y.; He, B.; Zeng, X.; Lai, K.; Gu, Z. Effect of sodium oleate as a buffer on the synthesis of superparamagnetic magnetite colloids. J. Colloid Interface Sci. 2010, 347, 1-7.
28. Voicu, G.; Grumezescu, V.; Andronescu, E.; Grumezescu, A.M.; Ficai, A.; Ghitulica, C.D.; Gheorghe, I.; Chifiriuc, M.C. Caprolactam-silica network, a strong potentiator of the antimicrobial activity of kanamycin against Gram-positive and Gram-negative bacterial strains. Int. J. Pharm. 2013, 446, 63-69.
29. Qian, Z.; Zhang, Z.; Chen, Y. A novel preparation of surface-modified paramagnetic magnetite/polystyrene nanocomposite microspheres by radiation-induced miniemulsion polymerization. J. Colloid Interface Sci. 2008, 327, 354-361.
30. Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Mihaiescu, D.E.; Vasile, B.S.; Bleotu, C. Syntehsis, characterization and biological evaluation of Fe3O4/C12 core/shell nanosystem. Lett. Appl. NanoBioSci. 2012, 1, 31-35.
31. Grumezescu, A.M.; Saviuc, C.; Chifiriuc, C.M.; Hristu, R.; Mihaiescu, D.E.; Balaure, P.; Stanciu, G.; Lazar, V. Inhibitory activity of Fe3O4/oleic acid/usnic acid-core/shell/extra-shell nanofluid on S. aureus biofilm development. IEEE Trans. NanoBioSci. 2011, 10, 269-274.
32. Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 1975, 66, 188-193.
33. Mogosanu, G.D.; Popescu, F.C.; Busuioc, C.J.; Pârvanescu, H.; Lascar, I. Natural products locally modulators of the cellular response: Therapeutic perspectives in skin burns. Rom. J. Morphol. Embryol. 2012, 53, 249-262.
34. Mogosanu, G.D.; Popescu, F.C.; Busuioc, C.J.; Lascar, I.; Mogoanta, L. Comparative study of microvascular density in experimental third-degree skin burns treated with topical preparations containing herbal extracts. Rom. J. Morphol. Embryol. 2013, 54, 107-113.
35. Saviuc, C.; Grumezescu, A.M.; Chifiriuc, M.C.; Bleotu, C.; Stanciu, G.; Hristu, R.; Mihaiescu, D.; Lazar, V. In vitro methods for the study of microbial biofilms. Biointerface Res. Appl. Chem. 2011, 1, 31-40.